Why We’re In a ‘Golden Age’ of Life Sciences Innovation
Exchanges
00:00
How Do You Assess the Risks in the Space?
In the near term there's going to be some challenges, particularly for companies who have recently gone public. But what we are seeing is firms able on the capital side, are able to continue to raise capital and new funds are being created. So you're going to see a shift. The best companies are going to continue to beale to get funded and grow. A little bit of the correction that we're seeing is, frankly, good and healthy for the space,. because it drives more rational application of capital.
Transcript
Play full episode
